Abstract
Introduction : Thea im of the study was to compare adalimumab or golimumab with infliximab in patients with moderately-to-severely active ulcerative colitis (UC). Material and methods : This paper was prepared according to the PRISMA guidelines. The systematic literature search was performed...

This publication has 43 references indexed in Scilit: